Results 261 to 270 of about 17,826,638 (304)

Cutaneous manifestations of B-cell chronic lymphocytic leukemia

International Journal of Hematology, 2020
Chronic lymphocytic leukemia (CLL) is a malignant lymphoproliferative disease characterized by the accumulation of immature monoclonal B lymphocytes in blood cells, bone marrow, spleen and lymph nodes. This is the most common type of leukemia among the Caucasoid race.
Elena A. Morozova, Olga Yu. Olisova, Eugene A. Nikitin   +2 more
openaire   +2 more sources

Chronic Myelomonocytic Leukemia Coexisting with B-cell Chronic Lymphocytic Leukemia

Leukemia & Lymphoma, 2003
Coexistence of B-cell chronic lymphocytic leukemia (B-CLL) and chronic myelomonocytic leukemia (CMML) is an unusal event, and to our knowledge, only four such cases have been reported in the literature. We report a 68-year-old white woman in whom these two diseases were diagnosed concomitantly.
Tadeusz, Robak, Halina, Urbańska-Ryś, Piotr, Smolewski, Ewa, Wawrzyniak, Anna, Korycka, Radzisław, Kordek, Jacek, Bartkowiak   +6 more
openaire   +2 more sources

B-cell function in patients with chronic lymphocytic leukemia

Klinische Wochenschrift, 1982
Using a reverse hemolytic protein A plaque assay, spontaneous and pokeweed mitogen (PWM)-induced immunoglobulin (Ig) secretion was determined in peripheral blood from 22 patients with B1-chronic lymphocytic leukemia (CLL), one patient with B2-CLL, and one patient with suppressor T-CLL. Diagnoses were established by cytological and histological criteria
G, Sieber, F, Herrmann, B, Enders, H, Rühl   +3 more
openaire   +2 more sources

Multidrug Resistance in B-Cell Chronic Lymphocytic Leukemia

Acta Haematologica, 2009
Multidrug resistance (MDR) was investigated in peripheral blood cells isolated from 40 patients with B cell chronic lymphocytic leukemia (B-CLL) and from 7 healthy volunteers, using a flow cytometric assay that detects cellular efflux of the fluorescent dye rhodamine 123 (Rh 123), which has been demonstrated to be transported from the cell by the P ...
I, Grulois, O, Fardel, B, Drenou, T, Lamy, P Y, Le Prisé, R, Fauchet   +5 more
openaire   +2 more sources

Assessment of a B-cell function in chronic lymphocytic leukemia

Clinical Immunology and Immunopathology, 1976
Abstract Chronic lymphocytic leukemia (CLL) patients were tested for the numbers of T cells, B cells, and cells secreting immunoglobin (Ig) by recently developed methods with antibody coated erythrocytes. Five of seven patients had higher percentages (72–90%) of B cells and lower percentages (4–17%) of T cells than normal controls.
A J, Strelkauskas, W C, Eby, G A, Molinaro, S, Dray   +3 more
openaire   +2 more sources

B-cell receptor signaling in chronic lymphocytic leukemia

Blood, 2011
AbstractThe B-cell receptor (BCR) is a key survival molecule for normal B cells and for most B-cell malignancies. Recombinatorial and mutational patterns in the clonal immunoglobulin (Ig) of chronic lymphocytic leukemia (CLL) have revealed 2 major IgMD-expressing subsets and an isotype-switched variant, each developing from distinct B-cell populations.
Stevenson, FK, Krysov, S, Davies, AJ, Steele, AJ, Packham, G   +4 more
openaire   +3 more sources

Myelomonocytic antigens in B-cell chronic lymphocytic leukemia

Leukemia Research, 1995
The clinical significance of myelomonocytic (MyMo) antigens in B-cell chronic lymphocytic leukemia (B-CLL) is unclear. We have analyzed the expression of MyMo antigens (CD13, CD14 (LeuM3, My4, Mo2), CD15, CD11b, CD11c, CD33 and CD68) on B-lymphocytes (CD19+) in 105 B-CLL patients and in 35 controls.
D, Tàssies, E, Montserrat, J C, Reverter, N, Villamor, M, Rovira, C, Rozman   +5 more
openaire   +2 more sources

11q13 Rearrangement in B Cell Chronic Lymphocytic Leukemia

Leukemia & Lymphoma, 1997
Translocation t(11;14)(q13;q32) and/or 11q13 rearrangements have been reported in various B cell immunoproliferative disorders. They appear to be frequent in mantle cell zone lymphoma (MZL) and rare in B-cell chronic lymphocytic leukemia (B-CLL). Discrimination between MZL and B-CLL is sometimes uncertain on the basis of morphology and immunophenotype.
F, Brizard, B, Dreyfus, F, Guilhot, J, Tanzer, A, Brizard   +4 more
openaire   +2 more sources

T-lymphocyte function in B-cell chronic lymphocytic leukemia

Clinical Immunology and Immunopathology, 1980
Summary. B‐enriched lymphocyte populations from patients with chronic lymphocytic leukaemia (CLL) were compared to B‐enriched lymphocyte populations from normal age‐matched controls for their ability to stimulate a proliferative response and to generate cytotoxic cells in allogeneic mixed lymphocyte cultures (MLC).
J A, Wolos, F R, Davey
openaire   +3 more sources

Chromosome studies in stimulated lymphocytes of B‐Cell chronic lymphocytic leukemias

Hematological Oncology, 1983
AbstractUsing a sister chromatid differentiation technique, cell cycle study of stimulated lymphocytes of B‐Cell chronic lymphocytic leukemia (B‐CLL) revealed their cell cycle progression to be similar to that of normal lymphocytes stimulated by T‐cell and various polyclonal B‐cell activators (PBA).
N, Sadamori, T, Han, J, Minowada, E, Cohen, A A, Sandberg   +4 more
openaire   +2 more sources